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Background: Obesity is associated with poor reproductive outcomes, but few reports have examined thawed
embryo transfer in obese women. Many studies have shown that increased lipid accumulation aggravates
vitrification injury in porcine and bovine embryos, but oocytes of these species have high lipid contents (63 ng and
161 ng, respectively). Almost nothing is known about lipids in human oocytes except that these cells are
anecdotally known to be relatively lipid poor. In this regard, human oocytes are considered to be similar to those of
the mouse, which contain approximately 4 ng total lipids/oocyte. To date, no available data show the impact of
obesity on vitrification in mouse embryos. The aim of this study was to establish a murine model of maternal
diet-induced obesity and to characterize the effect of obesity on vitrification by investigating the survival rate and
embryo developmental competence after thawing.
Methods: Prospective comparisons were performed between six–eight-cell embryos from obese and
normal-weight mice and between fresh and vitrified embryos. Female C57BL/6 mice were fed standard rodent
chow (normal-weight group) or a high-fat diet (obese group) for 6 weeks. The mice were mated, zygotes were
collected from oviducts and cultured for 3 days, and six–eight-cell embryos were then selected to assess lipid
content in fresh embryos and to evaluate differences in apoptosis, survival, and development rates in response to
vitrification.
Results: In fresh embryos from obese mice, the lipid content (0.044 vs 0.030, P<0.01) and apoptosis rate (15.1%
vs.9.3%, P<0.05)were significantly higher, the survival rate (83.1% vs. 93.1%, P<0.01) on day 5 was significantly lower,
and embryo development was notably delayed on days 3–5 compared with the normal-weight group. After
vitrification, no significant difference was found between thawed embryos from obese and normal-weight mice in
apoptosis, survival, and development rates on days 4 and 5. In both groups, pre- and post-vitrification embryo
apoptosis, survival, and development rates were similar.
Conclusions: This study demonstrated that differences in survival and developmental rates between embryos from
obese and normal-weight mice were eliminated after vitrification. Thus, maternal obesity does not aggravate
vitrification injury, but obesity alone greatly impairs pre-implantation embryo survival and development.
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Obesity is an important health concern, and its preva-
lence has tripled in reproductive-aged women since the
early 1970s. However, the impact of obesity on repro-
ductive outcome in women using assisted reproductive
technology (ART) has always been the subject of debate.
Several studies of ART have associated obesity with
worse reproductive outcomes than normal-weight
women, including increased gonadotropin dosage [1]
and cycle cancellation rate [2,3], decreased implantation
and clinical pregnancy rates [3,4], increased spontaneous
abortion rates [5,6], lower ongoing pregnancy and live
birth rates [4,5], and increased early preterm rates [7].
Few published studies have investigated thawed
embryo transfer in obese women [3]. In ART, embryo
cryopreservation is a cost-effective way to increase cu-
mulative pregnancy rates per oocyte retrieval cycle. Vit-
rification is a widely used and rapid method that briefly
exposes embryos to high concentrations of cryoprotect-
ant agents before ultrarapid cooling and storage in liquid
nitrogen.
All embryos suffer considerable morphological and
functional damage during cryopreservation, but the ex-
tent of injury and post-thaw survival and developmental
rates may vary greatly among species, developmental
stages, and origins. Many studies have shown that
increased lipid accumulation aggravates vitrification in-
jury in porcine and bovine embryos, and delipidation by
micromanipulation or the use of chemicals can signifi-
cantly reduce embryo sensitivity to chilling or cryo-
preservation [8-15]. The specific mechanism by which
lipid accumulation in the embryo influences cryotoler-
ance is unknown, but lipid peroxidation might account
for this reduced tolerance [16]. Therefore, elevated lipid
content in embryos might increase the production of
free radicals and stimulate embryo death [13]. However,
the lipid contents of bovine and porcine oocytes are very
high (63 and 161 ng/oocyte, respectively) which can’t ad-
equately evaluate the effects of lipid content in other
species [17,18].
The lipid content of oocytes was found to be signifi-
cantly higher in mice with diet-induced obesity than in a
control group [19]; we can thus infer that human
embryos would have greater lipid contents in obese than
in normal-weight individuals, which would aggravate
cryopreservation injury. Almost nothing is known about
lipids in the human oocyte, except that these cells are
anecdotally known to be relatively lipid poor. In this re-
gard, human oocytes are considered to be similar to
those of mice, which are estimated to have a total lipid
content of 4 ng/oocyte [20].
Female mice with diet-induced obesity have shown
delayed embryo development [21,22], but no available
data to date have shown the impact of obesity onembryo vitrification in mice. The aim of this study was
to establish a murine model of maternal diet-induced
obesity and to characterize the effect of obesity on vitri-
fication by investigating the survival rate and embryo de-
velopmental competence after thawing.
Methods
Mice, dietary intervention, and physiologic data collection
All experimental procedures were approved by the Eth-
ics Committee of Sun Yat-sen University. From 5 weeks
of age, female C57BL/6 mice (Laboratory Animal Ser-
vices, Sun Yat-sen University, Guangzhou, China) were
fed one of two diets for 6 weeks. The high-fat diet (obese
group, n= 45) provided 45% fat, 20% protein, and 35%
carbohydrate (D12451; Research Diets, Inc., New Bruns-
wick, NJ, USA), and the matched control diet (normal-
weight group; n= 45) provided 10% fat, 20% protein, and
70% carbohydrate (D12450B; Research Diets, Inc.). All
mice were provided with food and water ad libitum.
To verify the establishment of the obesity model, body
weight was recorded every week throughout the feeding
period. Blood samples were taken at 11 weeks of age
from a subset of mice (n= 10/group) after an 8-h fast
via cardiac puncture under anesthesia. Blood was
allowed to clot at room temperature, and samples were
then centrifuged at 4000 rpm for 10 min and serum was
removed. Serum samples were subjected to insulin ana-
lysis using a mouse insulin ultrasensitive enzyme-linked
immunosorbent assay kit (ALPCO Diagnostics, Salem,
NH, USA). Serum fasting blood glucose levels were
determined using a Roche Cobas Mira automated sam-
ple system (Roche Diagnostics Corporation, Castle Hill,
Australia). Cholesterol and triglyceride levels were mea-
sured using CHOD-PAP and TRG assay kits (Roche
Diagnostics Corporation), respectively.
Zygote collection and culture
All chemicals were obtained from Sigma-Aldrich Cor-
poration (St. Louis, MO, USA) unless specified
otherwise.
At 11 weeks of age, normal-weight and obese female
mice were ovulated with 10 IU pregnant mare serum go-
nadotropin, followed 48 h later by 10 IU human chori-
onic gonadotropin (hCG), via intraperitoneal injection.
The female mice were then mated with adult (10–14-
week-old) male mice of the same strain and checked for
the presence of a postcoital vaginal plug the following
morning. The mated female mice were sacrificed by cer-
vical dislocation 22–24 h after hCG injection, and
zygotes were collected from the oviducts in HEPES-
buffered ?-minimal essential medium (GIBCO BRL Invi-
trogen Australia, Mulgrave, Australia) supplemented
with 1mg/mL polyvinylpyrrolidone (PVP) to prevent
sticking. Following culture in G1 media (ver. 3; Vitrolife,
Ma et al. Reproductive Biology and Endocrinology 2012, 10:68 Page 3 of 8
http://www.rbej.com/content/10/1/68Göteborg, Sweden), at 66 h after hCG injection, grades I
and II (even or less even blastomeres, fragmentation <
10%, intact zona pellucida) six–eight-cell embryos were
selected to culture in G2 sequential medium (ver. 3;
Vitrolife) to the blastocyst stag, half of the six–eight-cell
embryos from each group was vitrified and thawed 5
days later, the fresh embryos served as controls.
All embryo culture media were equilibrated at 37°C in
5% CO2 and cultures were conducted in 30-μL drops
under mineral oil.
Embryo cryopreservation and thawing
The pretreatment, vitrification, and dilution media were
based on HEPES buffer. The pretreatment solution con-
tained 7.5% (v/v, 1.06 M) dimethyl sulfoxide (DMSO)
and 7.5% (v/v, 1.3 M) ethylene glycol (EG). The vitrifica-
tion solution contained 15% (v/v, 2.1 M) DMSO, 15% (v/
v, 2.6 M) EG, 5.9 mg/mL Ficoll 400, and 0.58 M sucrose.
The five-step dilution solutions contained 1 M, 0.5 M,
0.33 M, 0.2 M, and 0 M sucrose, respectively.
All vitrification processes were carried out at room
temperature. Five to eight embryos were equilibrated in
pretreatment solution for 2 min, then transferred to vit-
rification solution, loaded onto the tip of a 0.25-mL
straw in a minimum volume of vitrification solution, and
plunged into liquid nitrogen within 35–45 s.
After 5 days of storage in liquid nitrogen, the embryos
were transferred to a sucrose-free medium and then
subjected to a five-step thawing procedure (1 M: 1 min,
0.5 M: 1 min, 0.33 M: 2 min, 0.2 M: 3 min, 0 M: 5 min)
at 37°C. After thawing, embryos were cultured in G2
medium covered with mineral oil at 37°C in saturated
humidity and an atmosphere of 5% CO2. Embryo sur-
vival, developmental competence, and apoptosis rates
were then assessed, as described below.
Embryo developmental competence assessment
Embryo developmental competence was assessed using a
phase-contrast microscope at the following timepoints
after hCG injection [23]: 42 h (day 2), 66 h (day 3), 97 h
(day 4), and 114 h (day 5) in the fresh group; and 31 and
48 h after embryos were thawed in the vitrified group.
Embryos were recorded when normal cell numbers
and morphology were observed (i.e., two cells on day 2;
six–eight cells on day 3; morula, blastocyst, or expanded,
hatching or hatched blastocyst on days 4 and 5), frag-
mentation was <10%, and the zona pellucida was intact
(except in hatching or hatched blastocysts). Embryos in
which cell division events had ceased (indicating cellular
arrest) were categorized as degenerate.
The zygote cleavage rate on day 2 (number of embryos
cleaved on day 2/total number of one-cell embryos
recovered on day 1) and six–eight-cell embryo ratio on
day 3 (number of embryos scored morphologically ashaving six–eight cells on day 3/total number of two-cell
embryos on day 2) were compared between obese and
normal-weight groups. The proportions of embryos at
the morula, blastocyst, and expanded, hatching and
hatched blastocyst stages [number of embryos at each
stage/number of six–eight-cell embryos on day 3 (fresh)
or total number of thawed embryos (vitrified)] and
embryo degeneration rate [number of embryos in which
development had ceased/number of fresh six–eight-cell
embryos on day 3 (fresh) or number of thawed embryos
(vitrified)] on days 4 and 5 were compared between the
fresh obese and normal-weight and vitrified obese and
normal-weight groups to detect the effects of obesity
and vitrification on embryo developmental potential.
Lipid droplet staining
Lipophilic Nile Red dye was used to stain intracellular
neutral lipids in the fresh six–eight-cell embryos [24].
Nile Red was reconstituted in DMSO to a concentration
of 1 mg/mL and further diluted to a working concentra-
tion of 10 μg/mL in phosphate-buffered saline (PBS). To
prevent embryos from sticking to pipettes, 1 mg/mL
PVP was added to each solution used in this procedure.
The embryos were fixed in 4% paraformaldehyde-PBS
for 2 h and washed thoroughly in PBS before staining
with Nile Red for 1 h at 37°C. They were then rinsed
again in PBS and incubated in 1 μg/mL 4’,6-diamidino-2-
phenylindole dihydrochloride (DAPI) for 15 min in the
dark. After three additional washes in PBS to remove
excess DAPI, embryos were mounted on 10% (w/v) poly-
L-lysine–coated slides using 2-μL microdrops of Antifade
(Invitrogen, Carlsbad, CA, USA).
Images of each embryo were captured using an
LSM710 spectral scanning confocal microscope system
(Zeiss, Göttingen, Germany). Identical magnification and
gain settings were used for all samples. To examine lipid
concentration, the whole volume of each embryo on the
confocal image was sampled using a Z-stack consisting
of a set of adjacent optical sections taken at 3-μm inter-
vals. Total mean lipid content was calculated as the
mean fluorescence intensity of all sections of each
embryo using Image-Pro Plus software (ver. 6.0; Media
Cybernetics, Bethesda, MD, USA).
Assessment of DNA damage by TUNEL staining
Apoptosis rates were examined in six–eight-cell embryos
before and after vitrification using terminal deoxynu-
cleotidyl transferase-mediated 2’-deoxyuridine 5’-
triphosphate-biotin nick end-labeling (TUNEL) staining
[25]. The embryos were rinsed twice in 50-μL micro-
drops of PBS-PVP, fixed in 50-μL microdrops of 4% (w/
v) paraformaldehyde in PBS for 1 h, rinsed in PBS, and
then permeabilized in 0.5% (v/v) Triton X-100 for 30
min. Positive controls for the TUNEL assay were
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h in the dark. Positive controls and embryos were then
washed in PBS and incubated with 50 μL TUNEL reac-
tion mixture (Roche Diagnostics Corporation, Indian-
apolis, IN, USA) at 37°C for 1 h in the dark. Negative
controls were incubated in the absence of terminal deox-
ynucleotidyl transferase. After incubation, embryos were
rinsed in PBS and incubated in 1 μg/mL DAPI for 15
min in the dark. After three additional washes in PBS-
PVP, embryos were mounted on 10% (w/v) poly-L-
lysine–coated slides using 2-μL microdrops of Antifade
(Invitrogen). Images of each embryo were captured using
an LSM710 spectral scanning confocal microscope sys-
tem (Zeiss).
In each embryo, the total number of cells (blue fluor-
escence) and number of TUNEL-positive blastomeres
(green fluorescence) were counted with DAPI and GFD
filters, respectively, using a 40× objective. The apoptosis
rate was expressed as number of TUNEL-positive blasto-
meres/total cell number.
Statistical analyses
Statistical analyses were performed using the SPSS soft-
ware package (ver. 13.0; SPSS Inc., Chicago, IL, USA).
Normality was tested using the Kolmogorov–Smirnov
test. Differences between dietary groups in body weight,
serum metabolite index, and lipid droplet content were
determined using the independent t-test. The apoptosis,
survival, and development rates on each day were deter-
mined by χ2 analysis. For all analyses, P<0.05 was
defined as statistically significant.
Results
Metabolic indices and lipid content in normal-weight and
obese mice
After 6 weeks, mice fed a standard diet weighed 18.9 g
and those fed a high-fat diet was 21.0 g (P<0.001;
Table 1). Compared with the normal-weight group, the
obese group showed significantly higher fasting serum
insulin (0.27 vs. 0.61 ng/mL, P<0.001), triglyceride (1.1
vs. 1.8 mmol/L, P<0.001), cholesterol (3.1 vs. 5.1 mmol/
L, P<0.01) and glucose (4.2 vs. 6.0 mmol/L, P<0.05)Table 1 Average body weight and metabolite
concentration in normal-weight and obese female mice
Normal weight Obese P1
Final body weight (g) 18.9 ± 1.2 21.0 ± 1.3 <0.001
Glucose (mmol/L) 4.2 ± 1.0 6.0 ± 1.5 <0.05
Insulin (ng/ml) 0.3 ± 0.8 0.6 ± 1.0 <0.001
Triglycerides (mmol/L) 1.1 ± 0.4 1.8 ± 0.5 <0.001
Cholesterol (mmol/L) 3.1 ± 1.0 5.1 ± 1.0 <0.01
Notes: Values are means ± standard deviation. Body weight, n= 45 mice/group;
plasma metabolite concentrations, n= 10 mice per group. 1Independent t-test.levels (Table 1). The mean lipid fluorescence intensity in
six–eight-cell embryos was significantly higher in the
obese group than in the normal-weight group (0.044 vs.
0.030, P<0.01; Figure 1).
Maternal obesity impaired pre-implantation development
in fresh embryos
Zygotes recovered from obese and normal-weight female
mice were cultured to the blastocyst stage to establish
the effect of maternal obesity on embryo development.
Cleavage to the two-cell stage was comparable between
groups (P= 0.67; Table 2). The proportions of six–eight-
cell embryos were significantly lower in the obese group
than in the normal-weight group on day 3 (P= 0.04).
This delay in development persisted on days 4 and 5
(both P<0.05; Table 2) of culture. On day 4 of culture,
degeneration rates were similar between groups
(P>0.05); however, the degeneration rate on day 5 was
significantly higher in the obese group than in the
normal-weight group (P<0.05; Table 2).
Pre- and post-vitrification degeneration and development
in six–eight-cell embryos
The degeneration rates and developmental potentials of
fresh and thawed embryos were comparable in the obese
and normal-weight groups on days 4 and 5 of cultureFigure 1 Lipid droplet staining with Nile Red in fresh six–eight-
cell mouse embryos. Images are representative of eight-cell
embryos from normal-weight (A) and obese (B) mice. (C) Mean
fluorescence intensities of embryos (n= 40/group) in normal-weight
and obese groups; the difference between groups was significant
(P<0.05).
Table 2 Effect of maternal obesity and vitrification on







No. of zygotes 30.9 ± 1.9 30.3 ± 1.3 - - NS
Cleavage rate (%) 64.3 ± 5.2 61.2 ± 4.5 - - NS
Six–eight-cell ratio (%) 75.1 ± 5.3 62.4 ± 4.2 - - <0.05
Morula (%)
Day 4 19.5b 41.6c 34.2 42.2 <0.01
Day 5 5.7 9.1 10.6 10.8 NS
≥Early blastocyst (%)
Day 4 40.2 32.5 36.8 38.5 NS
Day 5 39.1 49.4 42.1 39.8 NS
≥Expanded blastocyst
(%)
Day 4 35.7b 18.1c 25.0 16.9 <0.01
Day 5 48.3b 24.6c 36.8 32.5 <0.01
Degeneration rate (%)
Day 4 4.6 7.8 3.9 2.4 NS
Day 5 6.9b 16.9c 10.5 16.9 <0.01
Notes: Data represent n= 10 mice/group (from 630 and 609 total zygotes in
normal-weight and obese females, respectively). Cleavage rate = number of
cleaved embryos on day 2/total number of one-cell embryos recovered.
Six–eight-cell ratio =mean number of embryos scored morphologically as
having six–eight cells/mean number of cleaved embryos on day 2. Day 4 and
5 data are expressed as mean number of embryos at each stage/mean
number of six–eight-cell embryos on day 3 (fresh) or total number of thawed
embryos (vitrified). Degeneration rate = number of embryos that have ceased
development/number of six–eight-cell embryos on day 3 (fresh) or number of
thawed embryos (vitrified). ≥Early blastocyst = early-, mid-, or late-stage
blastocyst. ≥Expanded blastocyst = expanded, hatching, or hatched blastocyst.
NS = not significant; aChi-squared test; b vs. c, P<0.01.
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vival and developmental competence in both diet
groups.
Developmental differences between embryos from obese
and normal-weight mice were eliminated after
vitrification
Degeneration rates and developmental competence were
similar in the obese and normal-weight groups on days 4
and 5 after the embryos were thawed (Table 2), in con-
trast to the developmental difference observed in fresh
embryos. These results demonstrate that differences in
embryo survival and development between obese and
normal-weight groups were eliminated after vitrification.
Pre and post-vitrification apoptosis rates in six–eight-cell
embryos
Before freezing, the apoptosis rate in six–eight-cell
embryos was significantly higher in the obese group then
in the normal-weight group (15.1% vs. 9.3%, P<0.05).
After freezing, apoptosis rates were more similarbetween groups (18.3% vs.13.0%, P>0.05). Pre- and post-
vitrification rates did not differ significantly in either
group.
Vitrification had no effect on embryo apoptosis. The
elevated lipid content in six–eight-cell embryos from
obese mice did not aggravate cryogenic injury, but obes-
ity alone increased apoptosis rates in fresh embryos
(Figure 2).
Discussion
This study documented cryotolerance in six–eight-cell
embryos in a murine model of diet-induced obesity.
High lipid content in embryos from obese mice did not
aggravate cryodamage during vitrification, although
obesity alone impaired embryo survival and develop-
ment. Differences in the survival and development of
embryos from obese and normal-weight mice were
eliminated after vitrification.
In this study, fasted obese mice showed significantly
elevated cholesterol, triglyceride, and blood glucose
levels, as well as hyperinsulinemia, compared with
normal-weight mice. This abnormal metabolic environ-
ment may have impaired early embryo development.
Minge et al. [21] found that embryos from obese mice
had significantly reduced on-time progression compared
with those from control mice, and that altered granulosa
cell phenotype and ovarian dysfunction were caused by
compromised metabolism due to excessive caloric intake
in mice with diet-induced obesity; these changes were
also observed under conditions of genetic mutation–
induced obesity [26-29]. The underlying mechanism
may be inhibited expression of lanosterol 14 alpha-
demethylase caused by a high-fat diet [30]; the lanosterol
14 alpha-demethylase–mediated sterol pathway is
involved in ovarian development [31], quality control of
oocyte meiotic maturation [32-34], fertilization, and
embryo developmental competence [35,36]. Another
possible mechanism may be low levels of follicle-
stimulating hormone (FSH) and luteinizing hormone
(LH) in obese mice. Inappropriately low LH and FSH
concentrations are prevalent in patients with obesity and
other features of metabolic syndrome (hypertension and
hyperlipidemia), this prevalence may be the result of in-
sulin resistance at the level of the gonadotropin-releasing
hormone (GnRH)-secreting neuron because insulin facil-
itates the secretion of GnRH from neuronal cell cultures
[37]. LH and FSH are two important stimulators of eggs
development and maturation [38,39].
The compromised metabolic environment induced by
a high-fat diet significantly increased the lipid contents
of mouse oocytes [19] and embryos, as our research
confirmed. A high-fat diet significantly reduced mito-
chondrial membrane potential in mature oocytes [19],
with significant consequences for developmental
G 
Figure 2 Representative confocal images illustrating apoptosis frequency in six–eight-cell mouse embryos subjected to TUNEL
analysis. Positive control embryo nuclei in the blue (A) and green (B) fluorescence channels, and (C) merged image. Embryo nuclei in the blue
(D) and green (E) fluorescence channels, and (F) merged image. (G) Apoptosis rates of fresh and thawed embryos in the normal-weight and
obese groups. Apoptosis rate = TUNEL+ blastomeres/total number of blastomeres. Each group contained 40–50 embryos. The apoptosis rate was
significantly higher in fresh embryos in the obese (vs. normal-weight) group, but did not differ between groups of thawed embryos.
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from mice fed a high-fat diet showed increased expres-
sion of the endoplasmic reticulum (ER) stress marker
genes ATF4 and GRP78, and increased apoptosis rates
were observed in granulosa and cumulus cells of mice
fed a high-fat diet [19]. Thus, lipid accumulation, ER
stress, mitochondrial dysfunction, and apoptosis are
markedly increased in COCs from mice fed a high-fat
diet. These results indicate that lipotoxicity may also
occur in the ovarian cells and oocytes of obese mice,
which may contribute to the reduced survival and
delayed development observed in response to obesity.Events that exert any kind of stress on an embryo,
such as thermal stress [44,45], oxidative stress [46], un-
favorable conditions in culture media composition
[47,48], and cryopreservation, are potential causes of
apoptosis. Mammalian oocytes and embryos have shown
high survival rates after vitrification [49,50], in which
ultrarapid cooling produces ice crystal–free, solid, glass-
like structures. The high survival rate after thawing and
the large proportion of normal spindle/chromosome
configurations [49,50] suggest that vitrification does not
adversely affect human embryo development, including
the ability to form spindles and continue normal cell
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embryos from obese mice significantly impaired embryo
developmental potential, but the stress generated by vit-
rification had no effect on embryo survival or develop-
mental competence in the obese or normal-weight
group. Thus, obesity, but not vitrification, negatively
affected embryo development and survival.
This article reports the first published research on the
effect of lipids on vitrification in a murine model. In
contrast to studies conducted in other species, we found
no difference in vitrification injury associated with
dietary-induced obesity. Discrepancies in findings be-
tween studies in mice and domestic animal species may
be explained by the markedly high lipid content in
embryos from the latter; the total lipid content per oo-
cyte is 4 ng in mice [20], in contrast to 161 ng in pigs,
63 ng in cattle, and 89 ng in sheep [17,18]. Thus, lipid
toxicity induced by high organ lipid content may be less
pronounced in mouse embryos than in domestic animal
embryos.
In contrast to the differences observed in fresh
embryos, survival and developmental potential were
similar in thawed embryos from obese and normal-
weight mice. These results are in accordance with pat-
terns observed in human ART outcome: the odds of
pregnancy failure increase with body mass index (BMI)
among women with autologous fresh cycles (BMI ≥ 25.0
kg/m2, OR= 1.10/cycle; BMI ≥ 50.0 kg/m2, OR= 2.29/
cycle) but not among those BMI < 45 kg/m2 with autolo-
gous thawed cycles; however significant difference from
BMI > 45 kg/m2 (BMI = 45.0–50.0 kg/m2, OR =1.45/
cycle) [3]. Taken together, these results suggest that em-
bryonic and endometrial factors may play a role in the
poor ART outcomes associated with obesity in autolo-
gous fresh cycles, whereas endometrial factors may play
a major role in autologous thawed cycles because
embryo quality differences are eliminated after
vitrification.Conclusions
Obesity had no effect on embryo vitrification injury in a
murine model, but it greatly reduced embryo develop-
ment and impaired embryo survival. These differences
were eliminated after vitrification. The study renews our
knowledge about the effect of high lipid content on vitri-
fication injury. Future research should seek to identify
differences in organelle function, total cell numbers, and
blastocyst implantation potential after the vitrification of
six–eight-cell embryos to elucidate the conclusion more
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